Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
The Journal of Infectious Diseases|July 5, 2005
Molecular diversity of HIV in AlbaniaMassimo Ciccozzi, Caterina Gori, Stefano Boros, et al.Nature|December 16, 2006
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreakTulio de Oliveira, Oliver G Pybus, Andrew Rambaut, et al.Journal of Virology|July 30, 2005
High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutationsFrancesca Ceccherini-Silberstein, Federico Gago, Maria Santoro, et al.AIDS (London, England)|July 29, 2004
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressureFrancesca Ceccherini-Silberstein, Fulvio Erba, Federico Gago, et al.Journal of Medical Virology|June 25, 2005
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programmeMaria Concetta Bellocchi, Federica Forbici, Leonardo Palombi, et al.BMC Infectious Diseases|July 18, 2009
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugsClaudia Alteri, Valentina Svicher, Caterina Gori, et al.The Journal of Infectious Diseases|April 30, 2004
Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohortValerio Tozzi, Mauro Zaccarelli, Pasquale Narciso, et al.Antiviral Therapy|October 26, 2011
Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usageValentina Svicher, Claudia Alteri, Anna Artese, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2004
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapyMauro Zaccarelli, Carlo Federico Perno, Federica Forbici, et al.The Journal of Antimicrobial Chemotherapy|September 7, 2010
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitorsFrancesca Ceccherini-Silberstein, Isabelle Malet, Lavinia Fabeni, et al.Pageof 4